Review

Published on 17 Aug 2021

Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects

in Respiratory Pharmacology

Xianbo Wu
Jianli Huang
Jie Wang
Yihua Xu
Xinwei Yang
Minghan Sun
Jianyou Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.707491

5,263 views
10 citations

Original Research

Published on 12 Aug 2021

Laryngopharyngeal pH Monitoring in Patients With Idiopathic Pulmonary Fibrosis

in Respiratory Pharmacology

Yiliang Su
Li Shen
Fen Zhang
Xing Jiang
Xiaofeng Jin
Yuan Zhang
Yang Hu
Ying Zhou
Qiuhong Li
Huiping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.724286

2,814 views
2 citations

Case Report

Published on 12 Aug 2021

Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report

in Respiratory Pharmacology

Damir Vukoja
Andrea Jurić
Zdravka Erkapić
Tomislav Pejić
Željko Zovko
Josipa Juričić
Jelena Pejić
Matea Ćorluka

Frontiers in Pharmacology

doi 10.3389/fphar.2021.684537

6,616 views
1 citation

Case Report

Published on 09 Aug 2021

Case Report: Can Inhaled Adenosine Attenuate COVID-19?

in Respiratory Pharmacology

Bruce D. Spiess
Michael Sitkovsky
Pierpaolo Correale
Nikolaus Gravenstein
Cynthia Garvan
Timothy E. Morey
Brenda G. Fahy
Leslie Hendeles
Thomas J. Pliura
Thomas D. Martin

Frontiers in Pharmacology

doi 10.3389/fphar.2021.676577

3,289 views
10 citations

Review

Published on 05 Aug 2021

Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases

in Respiratory Pharmacology

Theerasuk Kawamatawong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.518345

9,980 views
21 citations

Original Research

Published on 02 Aug 2021

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis

in Respiratory Pharmacology

Patrick O. Hanafin
Isabelle Sermet-Gaudelus
Matthias Griese
Matthias Kappler
Helmut Ellemunter
Carsten Schwarz
John Wilson
Marsha Tan
Tony Velkov
Gauri G. Rao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.577263

3,563 views
10 citations

Review

Published on 02 Aug 2021

Ferroptosis, a New Insight Into Acute Lung Injury

in Respiratory Pharmacology

Xiaofang Yin
Guisong Zhu
Qian Wang
Yuan Dong Fu
Juan Wang
Biao Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.709538

9,723 views
48 citations

Original Research

Published on 29 Jul 2021

The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study

in Respiratory Pharmacology

Jia-Wei Yang
Ping Jiang
Wen-Wen Wang
Zong-Mei Wen
Bei Mao
Hai-Wen Lu
Li Zhang
Yuan-Lin Song
Jin-Fu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.722537

3,266 views
3 citations

Original Research

Published on 28 Jul 2021

Electronic Cigarette Exposure Enhances Lung Inflammatory and Fibrotic Responses in COPD Mice

in Respiratory Pharmacology

Hongwei Han
Guangda Peng
Maureen Meister
Hongwei Yao
Jenny J. Yang
Ming-Hui Zou
Zhi-Ren Liu
Xiangming Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2021.726586

6,900 views
24 citations

Original Research

Published on 28 Jul 2021

The miR-130a-3p/TGF-βRII Axis Participates in Inhibiting the Differentiation of Fibroblasts Induced by TGF-β1

in Respiratory Pharmacology

Yanhong Liu
Yan Ding
Yapeng Hou
Tong Yu
Hongguang Nie
Yong Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2021.732540

2,426 views
7 citations

Original Research

Published on 28 Jul 2021

Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices

in Respiratory Pharmacology

Gwenda F. Vasse
Lisette Van Os
Marina De Jager
Marnix R. Jonker
Theo Borghuis
L. Tim Van Den Toorn
Pytrick Jellema
Eric S. White
Patrick Van Rijn
Martin C. Harmsen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.669037

4,051 views
9 citations

Original Research

Published on 27 Jul 2021

Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid in vivo Nasal Potential Difference Measurement Protocol

in Respiratory Pharmacology

P. Cmielewski
J. Delhove
M. Donnelley
D. Parsons

Frontiers in Pharmacology

doi 10.3389/fphar.2021.714452

2,370 views
4 citations

Mini Review

Published on 26 Jul 2021

Association Between SGLT2is and Cardiovascular and Respiratory Diseases: A Meta-Analysis of Large Trials

in Respiratory Pharmacology

Dao-Gen Yin
Mei Qiu
Xue-Yan Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.724405

3,642 views
15 citations

Review

Published on 23 Jul 2021

Autophagy Modulators From Chinese Herbal Medicines: Mechanisms and Therapeutic Potentials for Asthma

in Respiratory Pharmacology

Yun Zhang
Xing Wang
He Zhang
Hongmei Tang
Hang Hu
Songping Wang
Vincent Kam Wai Wong
Yuying Li
Jun Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2021.710679

8,025 views
6 citations

Original Research

Published on 22 Jul 2021

rhKGF-2 Attenuates Smoke Inhalation Lung Injury of Rats via Activating PI3K/Akt/Nrf2 and Repressing FoxO1-NLRP3 Inflammasome

in Respiratory Pharmacology

Zhonghua Fu
Zhengying Jiang
Guanghua Guo
Xincheng Liao
Mingzhuo Liu
Zhenfang Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.641308

4,542 views
19 citations

Original Research

Published on 19 Jul 2021

P-Rex1 Cooperates With TGFβR2 to Drive Lung Fibroblast Migration in Pulmonary Fibrosis

in Respiratory Pharmacology

Qing Liang
Yanhua Chang
Jing Liu
Yan Yu
Wancheng Qiu
Jiajia Li
Xu Yang
Guangchun Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2021.678733

2,036 views

Navigation group

Articles

Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects

Laryngopharyngeal pH Monitoring in Patients With Idiopathic Pulmonary Fibrosis

Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report

Case Report: Can Inhaled Adenosine Attenuate COVID-19?

Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis

Ferroptosis, a New Insight Into Acute Lung Injury

The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study

Electronic Cigarette Exposure Enhances Lung Inflammatory and Fibrotic Responses in COPD Mice

The miR-130a-3p/TGF-βRII Axis Participates in Inhibiting the Differentiation of Fibroblasts Induced by TGF-β1

Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices

Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid in vivo Nasal Potential Difference Measurement Protocol

Association Between SGLT2is and Cardiovascular and Respiratory Diseases: A Meta-Analysis of Large Trials

Autophagy Modulators From Chinese Herbal Medicines: Mechanisms and Therapeutic Potentials for Asthma

rhKGF-2 Attenuates Smoke Inhalation Lung Injury of Rats via Activating PI3K/Akt/Nrf2 and Repressing FoxO1-NLRP3 Inflammasome

P-Rex1 Cooperates With TGFβR2 to Drive Lung Fibroblast Migration in Pulmonary Fibrosis